PMID- 12709443 OWN - NLM STAT- MEDLINE DCOM- 20030820 LR - 20211203 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 278 IP - 26 DP - 2003 Jun 27 TI - RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. PG - 23278-84 AB - Tumor necrosis factor-alpha (TNF-alpha) and lymphotoxin-beta receptor (LTbetaR) signaling both play important roles in inflammatory and immune responses through activation of NF-kappaB. Using various deficient mouse embryonic fibroblast cells, we have compared the signaling pathways leading to NF-kappaB induction in response to TNF-alpha and LTbetaR activation. We demonstrate that LTbetaR ligation induces not only RelA/p50 dimers but also RelB/p50 dimers, whereas TNF-alpha induces only RelA/p50 dimers. LTbetaR-induced binding of RelB/p50 requires processing of p100 that is mediated by IKKalpha but is independent of IKKbeta, NEMO/IKKgamma, and RelA. Moreover, we show that RelB, p50, and p100 can associate in the same complex and that TNF-alpha but not LTbeta signaling increases the association of p100 with RelB/p50 dimers in the nucleus, leading to the specific inhibition of RelB DNA binding. These results suggest that the alternative NF-kappaB pathway based on p100 processing may account not only for the activation of RelB/p52 dimers but also for that of RelB/p50 dimers and that p100 regulates the binding activity of RelB/p50 dimers via at least two distinct mechanisms depending on the signaling pathway involved. FAU - Derudder, Emmanuel AU - Derudder E AD - Laboratoire Oncogenese, Differenciation et Transduction du Signal, CNRS UPR 9079, Institut Andre Lwoff, 7 rue Guy Moquet, 94801 Villejuif, France. FAU - Dejardin, Emmanuel AU - Dejardin E FAU - Pritchard, Linda L AU - Pritchard LL FAU - Green, Douglas R AU - Green DR FAU - Korner, Marie AU - Korner M FAU - Baud, Veronique AU - Baud V LA - eng GR - AI44828/AI/NIAID NIH HHS/United States GR - CA69381/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20030421 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (I-kappa B Proteins) RN - 0 (Ltbr protein, mouse) RN - 0 (Lymphotoxin beta Receptor) RN - 0 (NF-kappa B) RN - 0 (NF-kappa B p50 Subunit) RN - 0 (Nuclear Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Relb protein, mouse) RN - 0 (Transcription Factors) RN - 0 (Tumor Necrosis Factor-alpha) RN - 147337-75-5 (Transcription Factor RelB) RN - 9007-49-2 (DNA) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.10 (Chuk protein, mouse) RN - EC 2.7.11.10 (I-kappa B Kinase) RN - EC 2.7.11.10 (Ikbkb protein, mouse) RN - EC 2.7.11.10 (Ikbke protein, mouse) RN - EC 3.1.- (Endonucleases) RN - EC 3.1.- (Snd1 protein, mouse) SB - IM MH - Active Transport, Cell Nucleus MH - Animals MH - DNA/metabolism MH - Dimerization MH - Endonucleases MH - Fibroblasts/metabolism MH - Gene Expression Regulation MH - I-kappa B Kinase MH - I-kappa B Proteins/metabolism MH - Lymphotoxin beta Receptor MH - Mice MH - NF-kappa B/*metabolism MH - NF-kappa B p50 Subunit MH - Nuclear Proteins/metabolism/*physiology MH - Protein Binding MH - Protein Serine-Threonine Kinases/metabolism MH - Proto-Oncogene Proteins/antagonists & inhibitors/*metabolism MH - Receptors, Tumor Necrosis Factor/*metabolism/physiology MH - Transcription Factor RelB MH - Transcription Factors/antagonists & inhibitors/*metabolism MH - Tumor Necrosis Factor-alpha/*physiology EDAT- 2003/04/24 05:00 MHDA- 2003/08/21 05:00 CRDT- 2003/04/24 05:00 PHST- 2003/04/24 05:00 [pubmed] PHST- 2003/08/21 05:00 [medline] PHST- 2003/04/24 05:00 [entrez] AID - S0021-9258(20)86124-9 [pii] AID - 10.1074/jbc.M300106200 [doi] PST - ppublish SO - J Biol Chem. 2003 Jun 27;278(26):23278-84. doi: 10.1074/jbc.M300106200. Epub 2003 Apr 21.